PENTREXCILINA- acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide tablet 
Healthlife of USA

----------

PENTREXCILINA

Drug Facts

Active Ingredients (in each tablet)

Acetaminophen USP 325mg.........................................................Pain reliever/fever reducer

Guaifenesin USP 200mg..............................................................Expectorant

Phenylephrine HCL USP 5mg........................................................Decongestant

Dextromethorphan HBr USP 15mg................................................Antitussive

Purpose

Pain reliever/ fever reducer

Expectorant

Decongestant

Antitussive

Uses

Temporarily

Warnings: Liver Warning:

This product contains acetaminophen. Severe liver damage may occur if you take:

Allergy alert:

Acetaminophen may cause severe skin reactions. Symproms may include: skin reddening, blisters, rash if a skin reaction occurs, stop use and seek medical help right away.

Warning: A persistent cough may be a sign of a serious condition

Do not

Stop use and ask a doctor if:

symptoms do not improve, pain or fever persists or gets worse, new symptoms occur, redness or swelling is present, symptoms do not improve within 7 days or are accompanied by fever, cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition

Ask a doctor before use if you have:

heart disease, high blood pressure, thyroid disease, diabetes, difficulty in urination due to enlargement of the prostate gland, liver disease

Ask a doctor or pharmacist if you are

taking the blood thinning drug warfarin.

Do not exceed recommended dosage

if nervousness, dizziness, or sleeplessness occur, discontinue use consult a doctor.

If pregnant or breast-feeding,

ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not nnotice any signs or symptoms

Directions:

Adults and children 12 years of age and older: Take 2 tablets every 6 to 8 hours as needed, do not exceed 8 tablets in 24 hours, or as directed by a doctor. Children under 12 years, consult a doctor

Other Inforamtion:

Inactive Ingredients

maltodextrin, microcrystalline cellulose, povidone, silicon dioxide*, sodium starch glycolate, starch, stearic acid

(*may contain)

Questions or comments?

Call: 619-600-5632 (Mon-Fri 9am - 5pm EST)

Pentrexcilina
2 Tablets in a pouch

pentrexcilina-2

pentrexcilina-12-eng

pentrexcilina-72

PENTREXCILINA 
acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69517-155
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN325 mg
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE5 mg
DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE15 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POVIDONE (UNII: FZ989GH94E)  
STARCH, CORN (UNII: O8232NY3SJ)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeCAPSULESize16mm
FlavorImprint Code A15
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69517-155-066 in 1 PACKAGE01/05/2018
12 in 1 POUCH; Type 0: Not a Combination Product
2NDC:69517-155-7272 in 1 PACKAGE01/05/2018
22 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01201/05/2018
Labeler - Healthlife of USA (079656178)
Establishment
NameAddressID/FEIBusiness Operations
Vovantis Laboratories Private Limited650502151manufacture(69517-155)

Revised: 10/2023
Document Id: 083396b6-6a36-ffc7-e063-6294a90ad8e2
Set id: ae9ada14-0ec8-4c01-a874-237f2108936a
Version: 8
Effective Time: 20231021
 
Healthlife of USA